No Data
No Data
Envista Holdings Price Target Cut to $17.00/Share From $19.00 by Baird
Envista Holdings Is Maintained at Neutral by Baird
Baird Maintains Envista Holdings(NVST.US) With Hold Rating, Cuts Target Price to $17
Executive Reshuffles: Otis Worldwide, HSBC and Rockwell Automation in Focus
Envista Holdings: Hold Rating Maintained Amidst Executive Appointments and Uncertain Impact on Financial Performance
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Solid Biosciences (SLDB) and Lexeo Therapeutics, Inc. (LXEO)
No Data